Bulgaria vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Bulgaria
100.0%
in 2020
South-East Asia (WHO region)
94.0%
in 2024
Bulgaria rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bulgaria
- South-East Asia (WHO region)
How they compare
Bulgaria currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Bulgaria's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 6 years both countries report, Bulgaria has been ahead every year.
Bulgaria ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Bulgaria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 68.2% | 31.8% | Bulgaria |
| 2020s | 100.0% | 89.0% | 11.0% | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bulgaria or South-East Asia (WHO region)?
- Bulgaria, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2020.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bulgaria and South-East Asia (WHO region)?
- 6.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and South-East Asia (WHO region)?
- 6 years are reported by both, from 2010 to 2020.
- How do Bulgaria and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bulgaria ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.